The three-dimensional structures of tick carboxypeptidase inhibitor in complex with A/B carboxypeptidases reveal a novel double-headed binding mode
- PMID: 15961103
- DOI: 10.1016/j.jmb.2005.05.015
The three-dimensional structures of tick carboxypeptidase inhibitor in complex with A/B carboxypeptidases reveal a novel double-headed binding mode
Abstract
The tick carboxypeptidase inhibitor (TCI) is a proteinaceous inhibitor of metallo-carboxypeptidases present in the blood-sucking tick Rhipicephalus bursa. The three-dimensional crystal structures of recombinant TCI bound to bovine carboxypeptidase A and to human carboxypeptidase B have been determined and refined at 1.7 A and at 2.0 A resolution, respectively. TCI consists of two domains that are structurally similar despite the low degree of sequence homology. The domains, each consisting of a short alpha-helix followed by a small twisted antiparallel beta-sheet, show a high level of structural homology to proteins of the beta-defensin-fold family. TCI anchors to the surface of mammalian carboxypeptidases in a double-headed manner not previously seen for carboxypeptidase inhibitors: the last three carboxy-terminal amino acid residues interact with the active site of the enzyme in a way that mimics substrate binding, and the N-terminal domain binds to an exosite distinct from the active-site groove. The structures of these complexes should prove valuable in the applications of TCI as a thrombolytic drug and as a basis for the design of novel bivalent carboxypeptidase inhibitors.
Similar articles
-
The NMR structure and dynamics of the two-domain tick carboxypeptidase inhibitor reveal flexibility in its free form and stiffness upon binding to human carboxypeptidase B.Biochemistry. 2008 Jul 8;47(27):7066-78. doi: 10.1021/bi800403m. Epub 2008 Jun 18. Biochemistry. 2008. PMID: 18558717
-
Caught after the Act: a human A-type metallocarboxypeptidase in a product complex with a cleaved hexapeptide.Biochemistry. 2007 Jun 12;46(23):6921-30. doi: 10.1021/bi700480b. Epub 2007 May 17. Biochemistry. 2007. PMID: 17506531
-
Structure of a novel leech carboxypeptidase inhibitor determined free in solution and in complex with human carboxypeptidase A2.Nat Struct Biol. 2000 Apr;7(4):322-8. doi: 10.1038/74092. Nat Struct Biol. 2000. PMID: 10742178
-
The beta-defensin-fold family of polypeptides.Toxicon. 2004 Nov;44(6):581-8. doi: 10.1016/j.toxicon.2004.07.011. Toxicon. 2004. PMID: 15501283 Review.
-
Structure and mechanism of carboxypeptidase A.Adv Inorg Biochem. 1984;6:1-69. Adv Inorg Biochem. 1984. PMID: 6398961 Review. No abstract available.
Cited by
-
Carboxypeptidase inhibitors from Solanaceae as a new subclass of pathogenesis related peptide aiming biotechnological targets for plant defense.Front Mol Biosci. 2023 Nov 16;10:1259026. doi: 10.3389/fmolb.2023.1259026. eCollection 2023. Front Mol Biosci. 2023. PMID: 38033385 Free PMC article.
-
Crystal structure of novel metallocarboxypeptidase inhibitor from marine mollusk Nerita versicolor in complex with human carboxypeptidase A4.J Biol Chem. 2012 Mar 16;287(12):9250-8. doi: 10.1074/jbc.M111.330100. Epub 2012 Jan 31. J Biol Chem. 2012. PMID: 22294694 Free PMC article.
-
Flexibility of the thrombin-activatable fibrinolysis inhibitor pro-domain enables productive binding of protein substrates.J Biol Chem. 2010 Dec 3;285(49):38243-50. doi: 10.1074/jbc.M110.150342. Epub 2010 Sep 29. J Biol Chem. 2010. PMID: 20880845 Free PMC article.
-
Mammalian metallopeptidase inhibition at the defense barrier of Ascaris parasite.Proc Natl Acad Sci U S A. 2009 Feb 10;106(6):1743-7. doi: 10.1073/pnas.0812623106. Epub 2009 Jan 28. Proc Natl Acad Sci U S A. 2009. PMID: 19179285 Free PMC article.
-
Weak conservation of structural features in the interfaces of homologous transient protein-protein complexes.Protein Sci. 2015 Nov;24(11):1856-73. doi: 10.1002/pro.2792. Epub 2015 Sep 8. Protein Sci. 2015. PMID: 26311309 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources